摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

13-di-p-tosylamino-12-methoxy-9-oxo-9H-indolo[3,2,1-ij]quino[3,2-c]-1,5-naphthyridine-2-carboxylic acid methyl ester | 1013629-38-3

中文名称
——
中文别名
——
英文名称
13-di-p-tosylamino-12-methoxy-9-oxo-9H-indolo[3,2,1-ij]quino[3,2-c]-1,5-naphthyridine-2-carboxylic acid methyl ester
英文别名
Methyl 6-[bis-(4-methylphenyl)sulfonylamino]-7-methoxy-12-oxo-3,13,23-triazahexacyclo[11.10.1.02,11.04,9.014,19.020,24]tetracosa-1(24),2(11),3,5,7,9,14,16,18,20,22-undecaene-22-carboxylate
13-di-p-tosylamino-12-methoxy-9-oxo-9H-indolo[3,2,1-ij]quino[3,2-c]-1,5-naphthyridine-2-carboxylic acid methyl ester化学式
CAS
1013629-38-3
化学式
C38H28N4O8S2
mdl
——
分子量
732.794
InChiKey
BVLBWHFVIQTRFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.6
  • 重原子数:
    52
  • 可旋转键数:
    8
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    172
  • 氢给体数:
    0
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1-[7-di-p-tosylamino-3-hydroxymethyl-6-methoxyquinolin-2-yl]-9H-β-carboline-3-carboxylic acid methyl ester吡啶戴斯-马丁氧化剂 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 48.0h, 以45%的产率得到13-di-p-tosylamino-12-methoxy-9-oxo-9H-indolo[3,2,1-ij]quino[3,2-c]-1,5-naphthyridine-2-carboxylic acid methyl ester
    参考文献:
    名称:
    Synthesis of new lavendamycin analogues
    摘要:
    Friedlander reaction between methyl acetoacetate and 2,4-diaminobenzaldehyde provided quinoline 11. Subsequent tosylation, reduction, silylation, and then oxidation led to aldehyde 15. The latter was subjected to a Pictet-Spengler reaction with tryptophan methyl ester that yielded product 16, and then desilylation gave the lavendamycin analogue 17. This compound was oxidized by Dess-Martin periodinane, and the cyclized derivative 18 was obtained via a hemiaminal intermediate. The same sequence from 2,4-diamino-5-methoxybenzaldehyde or from (2,4-diaminophenyl)propan-3-one led to compounds 30 and 31, or 40 and 41, respectively. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2007.12.016
点击查看最新优质反应信息

文献信息

  • Synthesis of new lavendamycin analogues
    作者:Arnaud Nourry、Stéphanie Legoupy、François Huet
    DOI:10.1016/j.tet.2007.12.016
    日期:2008.2
    Friedlander reaction between methyl acetoacetate and 2,4-diaminobenzaldehyde provided quinoline 11. Subsequent tosylation, reduction, silylation, and then oxidation led to aldehyde 15. The latter was subjected to a Pictet-Spengler reaction with tryptophan methyl ester that yielded product 16, and then desilylation gave the lavendamycin analogue 17. This compound was oxidized by Dess-Martin periodinane, and the cyclized derivative 18 was obtained via a hemiaminal intermediate. The same sequence from 2,4-diamino-5-methoxybenzaldehyde or from (2,4-diaminophenyl)propan-3-one led to compounds 30 and 31, or 40 and 41, respectively. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

长春考酯 长春曲尔 铁屎米酮N氧化物 铁屎米酮 苦木西碱Q 温可纳特 9-羟基铁屎米酮 9-甲氧基铁屎米酮N氧化物 9-甲氧基-6H-吲哚并[3,2,1-De][1,5]萘啶-6-酮 9,10-二甲氧基铁屎米酮 7,14-二苯基二吲哚并[3,2,1-去:3',2',1'-ij][1,5]萘啶-6,13-二酮 5-羟基-6-铁屎米酮 5-羟基-4-甲氧基铁屎米酮 5-甲氧基铁屎米酮 4,5-二甲氧基铁屎米酮 11-羟基-6H-吲哚并[3,2,1-de][1,5]萘啶-6-酮 11-甲基-20,21-二去甲埃那美宁 10-羟基-6H-吲哚并[3,2,1-de][1,5]萘啶-6-酮 1-羟基-6-铁屎米酮 1,2,3,3a,4,5-六氢铁屎米酮 1,2,3,3a,4,5-六氢-3-甲基-6H-吲哚并(3,2,1-de)(1,5)萘啶-6-酮单甲烷磺酸盐 1,2,3,3a,4,5-六氢-3-乙基-6H-吲哚并(3,2,1-de)(1,5)萘啶-6-酮 (3S,16S)-17alpha,21-环氧-14,15-二氢-14alpha-羟基-12-甲氧基埃那美宁-14-羧酸甲酯 4-[2-[[(15S,17R,19R)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-yl]oxy]ethyl]morpholine (+/-)-deethyleburnamine (+/-)-16-epideethyleburnamine 3-butyl-4-methoxycanthin-5,6-dione 3-butyl-9-methoxycanthin-5,6-dione 4-methoxy-5-propoxycanthinone 4-methoxy-5-sec-butoxycanthinone 4-methoxy-5-butoxycanthinone 4-ethyl-3-methylcanthin-5,6-dione 10-bromo-4-methoxy-3-methylcanthin-5,6-dione 8,10-dibromo-3-methylcanthin-5,6-dione 4-methoxy-5-(2-bromoethoxy)canthinone 7,14-bis(5'-bromo-3'-dodecyl-[2,2'-bithiophen]-5-yl)diindolo[3,2,1-de:3',2',1'-ij][1,5]naphthyridine-6,13-dione 7,14-bis(5'-hexyl-[2,2'-bithiophen]-5-yl)diindolo[3,2,1-de:3',2',1'-ij][1,5]naphthyridine-6,13-dione 7,14-bis(3'-dodecyl-[2,2'-bithiophen]-5-yl)diindolo[3,2,1-de:3',2',1'-ij][1,5]naphthyridine-6,13-dione ethyl (2S,3aS,6S)-6-(3,3-dimethyl-2-oxobutyl)-2,3,3a,4,5,6-hexahydro-1H-indolo<3,2,1-de><1,5>naphthyridine-2-carboxylate ethyl (2S,3aS,6S)-6-(2-methyl-2-propenyl)-2,3,3a,4,5,6-hexahydro-1H-indolo<3,2,1-de><1,5>naphthyridine-2-carboxylate trans-11-methoxydeethyleburnamonine 3-benzyl-10-methoxy-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one 10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridine-3-oxide 4-methoxy-5-isobutoxycanthinone 3-methylcanthin-6-on-3-ium p-toluenesulfonate 6-methyl-5-phenyl-4H-indolo[3,2,1-de][1,5]naphthyridin-4-one (3aα,6β)-3-Benzyl-2,3,3a,4,5,6-hexahydro-1H-indolo<3.2.1-de><1.5>naphthyridin-6-ol 5-acetoxycanthin-6-one 3,4-diethyl-2,3,3a,4,5,6-hexahydro-6-oxo-1H-indolo(3,2,1-de)(1,5)-naphthyridine N-oxide-benzo[e]canthin-6-one